Letters to the Editor 195 patients. The authors reported that insulin-dependent diabetic patients, in whom left ventricular ejection fraction (EF) as assessed by radionuclide ventriculography was normal at rest, had a poor increase or even a decrease in EF during dynamic exercise. Coronary angiography and endomyocardial biopsy were performed on 8 of the 16 patients with an abnormal EF response to dynamic exercise. All these 8patients had normal coronary arteries, but biopsy specimens showed arteriolar wall thickening and interstitial fibrosis in 5 patients and basement membrane thickening suggestive of diabetic microangiopathy in 2 patients. It is logical to consider that diabetic microangiopathy involving myocardium may be causally related to the impaired left ventricular function observed in these patients, but, as the authors emphasize, other factors may also be involved. There is both experimental and clinical evidence to suggest that metabolic abnormalities may play a role in this respect. Thus, impaired left ventricular function or diabetic cardiomyopathy in experimental diabetes is corrected with insulin therapy [2, 3]. We reported some years ago an improvement of systolic time intervals (STI) in a group of newly diagnosed Type 2 (non-insulin-dependent) diabetic patients after starting diet therapy for diabetes. The correction in STI was correlated with the decline in fasting blood glucose level. Furthermore, physical working capacity of the diabetic patients improved concomitantly with the correction of STI and hyperglycaemia [4] . The results yielded indirect evidence for reversibility of impaired left ventricular function. Recently, we evaluated left ventricular systolic function at rest and during exercise in 9 Type 2 diabetic patients with low postglucagon Cpeptide, indicating partial insulin deficiency. Before starting insulin treatment these patients showed a prolonged pre-ejection period (PEP) and an elevated PEP/LVET-ratio at STI-registration. In addition, the patients had a poor increase in EF during exercise as assessed by radionuclide ventriculography. After starting insulin therapy the metabolic control improved; concomitantly the abnormalities in STI changed to the normal direction, and EF response to dynamic exercise improved significantly (J. Mustonen et al, unpublished results), confirming our previous findings on newly diagnosed Type 2 diabetes. Therefore, we emphasize that metabolic disturbances, e.g. hyperglycaemia, insulin resistance or other related metabolic abnormalities, may play an important role in the pathogenesis of left ventricular dysfunction in patients with Type 2 diabetes. This dysfunction is not necessarily a "long-term" complication of diabetes, since it may be present already at the time of diagnosis of Type 2 diabetes and, as observations show, it may be reversible by improved metabolic control.
More on the question of a specific heart disease in diabetes Dear Sir, I was interested to read the recent report by Fisher et al. [1] in which the authors conclude that abnormalities in left ventricular function in diabetic patients with normal coronary angiography are due to underlying specific diabetic heart disease.
The presence of fibrosis and basement membrane thickening in biopsy specimens from hearts of diabetic patients has been previously reported. However, the authors' histological data is based on only 8 patients; only 5 of the patients showed interstitial fibrosis and only 2 showed basement membrane thickening. The authors themselves comment that the latter observation may well be due to artefact. While they have attempted to relate these pathological features to measurements of left ventricular function, this is a very small number of patients on which to base firm conclusions. In addition, their specimens were from the right ventricle while they were measuring left ventricular function.
It has been shown [2, 3] that left ventficular function may vary over time, depending on diabetic control, and a one-off measurement of left ventricular function need not imply permanent change. The authors have carded out their measurements once only, and cannot conclude that any observed abnormalities of left ventricular function are fixed or permanent. Under these circumstances, it is invalid to relate histological conclusions to functional studies.
In contrast to the authors' conclusions, I would suggest that their evidence is not substantive enough to support the concept of a specific heart disease in diabetes, although this remains a possibility. They may well have added a further piece to the jigsaw which in time, hopefully, will become completed.
Yours sincerely, A. D. B. Harrower
